Continue to Site

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Reveals Phase II Results for Cannabidiol Gel Therapy for Fragile X Syndrome

Market Summary > Current Price

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.